The influenza pandemic, known as influenza, is an acute respiratory epidemic caused by influenza viruses. The influenza virus is classified into categories A, B, C and D, of which influenza A and B can cause seasonal epidemics. The rapid spread and high incidence of influenza pose a serious threat to human health. This paper provides details on the treatment of influenza.
Clinical performance The clinical behaviour of influenza is diverse and often acute, with major symptoms including fever, headaches, myocardia and general discomfort. The temperature can be 39°C to 40°C and can be cold, cold, mixed with all-body muscle arthritis, lack of strength and appetite, often with throat pains, coughs, nose plugs, slugs, post-brain discomfort, etc. Some patients suffer from mild or no symptoms. Children tend to have higher levels of fever than adults, with more signs of digestive tracts such as nausea, vomiting and diarrhoea in case of type B influenza. The pathology of those without complications is more self-restricted than the onset of the disease.3 to 4 days later, the body temperature gradually recedes and the overall symptoms improve, but coughing and physical recovery take between 1 and 2 weeks.
1. Clinical diagnosis – based on the patient ‘ s epidemiological history, clinical performance and laboratory findings. – The influenza pandemic season, with clinical manifestations of the above-mentioned influenza, with a clear history of exposure of influenza patients and an initial diagnosis of influenza. Laboratory diagnosis – viral nucleic acid detection: The detection of influenza virus nucleic acid in respiratory specimens (snose-sorting, swab-sorting, bronchial extraction, slurry, etc.) using RT-PCR (reversible polymeric chain reaction) method is the main method of current influenza diagnosis, with high proxies of speed, sensitivity and specificity. – Antiviral testing: Rapid diagnostic reagents are used to test influenza virus antigens in respiratory specimens, which are simple and fast to produce results within minutes, but with relatively low sensitivity and specificity. – Serobiology: The detection of influenza virus antibodies in the patient ‘ s serum and the dynamic observation of a four-fold or more increase in the price of double serum antibodies during acute and recovery periods.
1. General treatment – Patients should be careful to rest, drink more water and eat more easily. – To monitor closely the evolution of the situation, particularly among children and elderly persons, and to receive timely medical treatment in the event of complications. 2. Treatment of ailments – People with a high heat can undergo physical cooling or application of athermals, such as acetaminophenol, brophen, etc. – Cough coughers give cough medicine. Antiviral treatment – Anti-influenza virus drugs should be used as early as possible within hours of the onset of the disease in order to mitigate symptoms, shorten the pathology and reduce complications. – Neurosuramate inhibitors: both influenza A and B are effective, and common drugs are Ostawe, Zanamibe, Paramive, etc. – M2 Ion-channel retardant: only effective for influenza A virus, with drugs of gold-goldane and ethylamine, but not recommended for individual use because of the current high resistance rate of influenza virus. 4. There are cases of viral myocardiitis in some patients, or co-infections of the respiratory tract, viral pneumonia, and impotence, chest and panic. It is generally more serious and requires inpatient observation and treatment to prevent complications such as heart failure, heart disorder and respiratory failure, which in turn endangers life.
1. Vaccination – Influenza vaccination is the most effective means of preventing influenza and can significantly reduce the risk of influenza and serious complications among those vaccinated. – Influenza vaccine is updated annually and should be administered before the flu season. It is recommended that people aged six months and above be vaccinated against influenza each year, especially the priority groups of the elderly, children, pregnant women, chronically ill and medical personnel. 2. Drug prevention – People with high risk of influenza complications who are not vaccinated or who have not acquired immunity from vaccination may be considered for prevention using anti-influenza virus drugs. – Drug prevention is not a substitute for vaccination and should be used under the supervision of a doctor. 3. Day-to-day protection – maintain good hygiene practices, wash hands and avoid touching eyes, mouths and noses with hands. – Keep the environment clean and ventilated and minimize human and air-contaminated sites. – In the flu pandemic season, wear masks to avoid close contact with flu patients. In short, influenza is a common respiratory epidemic, and timely and accurate diagnosis and effective treatment are essential to control conditions and reduce complications. At the same time, strengthening preventive measures and raising public self-protection awareness are key to preventing influenza. Comprehensive measures such as vaccination, drug prevention and routine protection can effectively reduce the incidence and spread of influenza and safeguard the health of the population.
